PepGen Inc. (PEPG) income statement
PEPGNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.78−0.15 (-3.82%)
Close on Nov 20, 2026Market cap $261.80MP/E –Yield –
PepGen Inc. financial ratios
See a number that looks wrong?
Close on Nov 20, 2026Market cap $261.80MP/E –Yield –
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Returns on capital | ||||||
| Return on equity | -67.4% | -79.3% | -54.6% | -93.7% | 141.9% | – |
| Return on assets | -55.2% | -61.2% | -43.6% | -38.3% | -19.0% | – |
| Return on tangible assets | -55.2% | -61.2% | -43.6% | -38.3% | -19.0% | – |
| Return on capital employed | -63.4% | -75.3% | -52.3% | -41.2% | -20.3% | – |
| NOPAT | -$73.95M | -$77.21M | -$66.97M | -$53.96M | -$21.42M | – |
| Cash flow quality | ||||||
| OCF / Net income | 0.91 | 0.92 | 0.88 | 0.86 | 0.83 | – |
| FCF / OCF | 100.3% | 100.6% | 103.8% | 106.3% | 102.2% | – |
| FCF / Net income | 0.91 | 0.92 | 0.91 | 0.91 | 0.85 | – |
| FCF / EBITDA | 88.8% | 86.1% | 85.7% | 92.9% | 85.8% | – |
| Unlevered free cash flow | -$81.90M | -$82.87M | -$71.60M | -$63.02M | -$23.10M | – |
| Levered free cash flow | -$81.90M | -$82.87M | -$71.60M | -$63.02M | -$23.10M | – |
| Efficiency | ||||||
| CapEx to OCF | -0.32% | -0.60% | -3.8% | -6.3% | -2.2% | – |
| CapEx to depreciation | 0.19 | 0.33 | 2.17 | 7.51 | 2.50 | – |
| Liquidity | ||||||
| Current ratio | 11.94 | 7.41 | 6.43 | 9.88 | 13.56 | – |
| Quick ratio | 11.94 | 7.41 | 6.43 | 9.88 | 13.56 | – |
| Cash ratio | 11.74 | 7.20 | 6.30 | 9.65 | 12.88 | – |
| Working capital | $138.32M | $107.07M | $95.15M | $167.26M | $129.67M | – |
| Net current asset value | $124.50M | $91.50M | $78.05M | $148.27M | $129.44M | – |
| Leverage | ||||||
| Assets to equity | 1.18 | 1.27 | 1.32 | 1.21 | -4.48 | – |
| Per share | ||||||
| EPS (basic) | -2.12 | -2.85 | -3.30 | -4.42 | -30.27 | – |
| EPS (diluted) | -2.12 | -2.85 | -3.30 | -4.42 | -30.27 | – |
| Book value per share | 2.14 | 3.64 | 4.55 | 7.58 | -33.29 | – |
| Tangible book value per share | 2.14 | 3.64 | 4.55 | 7.58 | -33.29 | – |
| Cash per share | 2.16 | 3.68 | 4.63 | 7.66 | 137.92 | – |
| Operating cash flow per share | -1.19 | -2.53 | -2.90 | -2.50 | -23.45 | – |
| Free cash flow per share | -1.19 | -2.54 | -3.01 | -2.66 | -23.97 | – |
| CapEx per share | 0.0038 | 0.02 | 0.11 | 0.16 | 0.52 | – |
| Valuation at period end | ||||||
| Market cap | $215.48M | $111.35M | $161.56M | $132.16M | – | – |
| Enterprise value | $51.78M | -$27.55M | $32.02M | -$63.62M | – | – |
| P/B | 1.5x | 0.9x | 1.5x | 0.7x | – | – |
| P/TBV | 1.5x | 0.9x | 1.5x | 0.7x | – | – |
| P/OCF | -2.6x | -1.4x | -2.3x | -2.2x | – | – |
| EV/EBITDA | – | 0.3x | – | 0.9x | – | – |
| EV/EBIT | – | 0.3x | – | 0.9x | – | – |
| EV/OCF | -0.6x | 0.3x | -0.5x | 1.1x | – | – |
| EV/FCF | – | 0.3x | – | 1.0x | – | – |
| Earnings yield | -41.6% | -80.8% | -48.7% | -52.3% | – | – |
| FCF yield | -38.0% | -74.4% | -44.3% | -47.7% | – | – |
| Per employee | ||||||
| Total employees | 56 | 81 | 64 | 45 | 45 | 45 |
| Operating profit per employee | -$1.67M | -$1.21M | -$1.32M | -$1.52M | -$602.42K | – |
| Net income per employee | -$1.60M | -$1.11M | -$1.23M | -$1.54M | -$606.24K | – |
| Free cash flow per employee | -$1.46M | -$1.02M | -$1.12M | -$1.40M | -$513.31K | – |
| Growth | ||||||
| EBIT 1Y growth | 4.2% | -15.3% | -24.1% | -151.9% | – | – |
| EBITDA 1Y growth | 4.2% | -15.2% | -23.3% | -152.0% | – | – |
| Net income 1Y growth | 0.36% | -14.4% | -13.8% | -153.3% | – | – |
| Diluted EPS 1Y growth | 25.6% | 13.6% | 25.3% | 85.4% | – | – |
| Operating cash flow 1Y growth | 0.89% | -19.4% | -16.4% | -162.2% | – | – |
| Free cash flow 1Y growth | 1.2% | -15.7% | -13.6% | -172.8% | – | – |
| CapEx 1Y growth | -46.9% | -80.9% | -30.8% | 651.0% | – | – |
| CapEx 3Y CAGR | -58.7% | -0.20% | – | – | – | – |
| Total assets 1Y growth | 15.3% | 5.5% | -34.2% | 51.4% | – | – |
| Total assets 3Y CAGR | -7.2% | 1.7% | – | – | – | – |
| Total equity 1Y growth | 24.3% | 9.4% | -39.6% | 659.9% | -404.4% | – |
| Total equity 3Y CAGR | -6.4% | – | – | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.